ArticleVirology journal2026

miR-194-5p targets SOCS2 to predict pegIFNα treatment response in HBeAg-positive chronic hepatitis B patients.

Yanling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.